NCT05541783

Brief Summary

The aim of this study is comparing the short-term quality of life between laparoscopy-assisted distal gastrectomy and totally laparoscopic distal gastrectomy for gastric cancer.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
213

participants targeted

Target at P50-P75 for not_applicable gastric-cancer

Timeline
Completed

Started Sep 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 6, 2022

Completed
9 days until next milestone

First Posted

Study publicly available on registry

September 15, 2022

Completed
Same day until next milestone

Study Start

First participant enrolled

September 15, 2022

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 15, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 15, 2025

Completed
Last Updated

July 25, 2025

Status Verified

July 1, 2025

Enrollment Period

2.3 years

First QC Date

September 6, 2022

Last Update Submit

July 23, 2025

Conditions

Keywords

Gastric cancer,Laparoscopic distal gastrectomy

Outcome Measures

Primary Outcomes (1)

  • Scores on the physical function and pain symptom scales of EORTC QLQ-C30 questionnaire

    Scores on the physical function and pain symptom scales of EORTC QLQ-C30 questionnaire at 30 days postoperatively

    30 days postoperatively

Secondary Outcomes (3)

  • Scores on the other scales of EORTC QLQ-C30 questionnaire postoperatively

    30 days postoperatively

  • Scores on EORTC QLQ-C30 questionnaire

    7 days and 90 days postoperatively

  • Scores on the scales of EORTC QLQ-STO22 questionnaire postoperatively

    7,30 and 90 days postoperatively

Study Arms (2)

Laparoscopy-assisted distal gastrectomy

ACTIVE COMPARATOR

The patients who are assigned to LADG group undergo extracorporeal anasto- mosis for gastrointestinal reconstruction.

Procedure: laparoscopy-assisted distal gastrectomy Group

Totally laparoscopic distal gastrectomy

EXPERIMENTAL

The patients who are allocated to TLDG group undergo intracorporeal anastomosis for the recovery of gastrointes- tinal continuity after gastrectomy.

Procedure: Totally laparoscopic distal gastrectomy

Interventions

LADG

Laparoscopy-assisted distal gastrectomy

TLDG

Totally laparoscopic distal gastrectomy

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 20-80 years;
  • Patients had an Eastern Cooperative Oncology Group performance status score of 0 or 1;
  • Patients had histologically confirmed gastric adenocarcinoma (tumor size\<5cm) at clinical stage I-III with T1-4aN0-2M0 excluding T4b or N3 tumors, according to the of the American Joint Committee on Cancer classification system, eighth edition;
  • Patients were expected to undergo laparoscopic distal gastrectomy with D2 lymphadenectomy.

You may not qualify if:

  • Patients had bulky regional lymph nodes (larger than 3 cm at the long diameter) or possible distant metastasis in preoperative evaluation
  • Patients had history of chemotherapy, radiotherapy, immunotherapy or target therapy;
  • Patients had any concurrent or previous malignant tumor;
  • Patients had unstable cardiovascular, respiratory, kidney, or liver disease and poorly controlled hypertension, diabetes, mental disorders; history of upper abdominal surgery (except laparoscopic cholecystectomy).
  • Patients were histologically proven gastric adenocarcinoma (by preoperative gastrofiberscopy).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fudan University Shanghai Cancer Center

Shanghai, Shanghai Municipality, China

Location

MeSH Terms

Conditions

Stomach Neoplasms

Condition Hierarchy (Ancestors)

Gastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesStomach Diseases

Study Officials

  • Dazhi Xu, PHD, MD

    Fudan University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PHD,MD

Study Record Dates

First Submitted

September 6, 2022

First Posted

September 15, 2022

Study Start

September 15, 2022

Primary Completion

January 15, 2025

Study Completion

January 15, 2025

Last Updated

July 25, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations